These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 35012613)
1. Incidence of breast cancer subtypes in immigrant and non-immigrant women in Norway. Hjerkind KV; Johansson ALV; Trewin CB; Russnes HG; Ursin G Breast Cancer Res; 2022 Jan; 24(1):4. PubMed ID: 35012613 [TBL] [Abstract][Full Text] [Related]
2. Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study. Cherbal F; Gaceb H; Mehemmai C; Saiah I; Bakour R; Rouis AO; Boualga K; Benbrahim W; Mahfouf H Breast Dis; 2015; 35(2):95-102. PubMed ID: 25736840 [TBL] [Abstract][Full Text] [Related]
3. Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort. Johansson ALV; Trewin CB; Hjerkind KV; Ellingjord-Dale M; Johannesen TB; Ursin G Int J Cancer; 2019 Mar; 144(6):1251-1261. PubMed ID: 30367449 [TBL] [Abstract][Full Text] [Related]
4. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program. Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999 [TBL] [Abstract][Full Text] [Related]
5. Disparities in the risk of the ER/PR/HER2 breast cancer subtypes among Asian Americans in California. Parise C; Caggiano V Cancer Epidemiol; 2014 Oct; 38(5):556-62. PubMed ID: 25172158 [TBL] [Abstract][Full Text] [Related]
6. Breast cancer in Ethiopia: evidence for geographic difference in the distribution of molecular subtypes in Africa. Hadgu E; Seifu D; Tigneh W; Bokretsion Y; Bekele A; Abebe M; Sollie T; Merajver SD; Karlsson C; Karlsson MG BMC Womens Health; 2018 Feb; 18(1):40. PubMed ID: 29444670 [TBL] [Abstract][Full Text] [Related]
7. Relationship of established risk factors with breast cancer subtypes. McCarthy AM; Friebel-Klingner T; Ehsan S; He W; Welch M; Chen J; Kontos D; Domchek SM; Conant EF; Semine A; Hughes K; Bardia A; Lehman C; Armstrong K Cancer Med; 2021 Sep; 10(18):6456-6467. PubMed ID: 34464510 [TBL] [Abstract][Full Text] [Related]
8. Geographic differences in the distribution of molecular subtypes of breast cancer in Brazil. Carvalho FM; Bacchi LM; Pincerato KM; Van de Rijn M; Bacchi CE BMC Womens Health; 2014 Aug; 14():102. PubMed ID: 25174527 [TBL] [Abstract][Full Text] [Related]
9. Reproductive history differs by molecular subtypes of breast cancer among women aged ≤ 50 years in Scotland diagnosed 2009-2016: a cross-sectional study. Chitkara A; Mesa-Eguiagaray I; Wild SH; Hall PS; Cameron DA; Sims AH; Figueroa JD Breast Cancer Res Treat; 2022 Nov; 196(2):379-387. PubMed ID: 36116093 [TBL] [Abstract][Full Text] [Related]
10. Breast cancer molecular subtypes and receptor status among women at Potchefstroom Hospital: a cross-sectional study. Kakudji BK; Mwila PK; Burger JR; du Plessis JM; Naidu K Pan Afr Med J; 2021; 38():85. PubMed ID: 33889251 [TBL] [Abstract][Full Text] [Related]
11. Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery. Pata G; Guaineri A; Bianchi A; Amoroso V; Pasinetti N; Pasini M J Surg Res; 2019 Apr; 236():288-299. PubMed ID: 30694768 [TBL] [Abstract][Full Text] [Related]
12. The impact of molecular subtype on breast cancer recurrence in young women treated with contemporary adjuvant therapy. Alabdulkareem H; Pinchinat T; Khan S; Landers A; Christos P; Simmons R; Moo TA Breast J; 2018 Mar; 24(2):148-153. PubMed ID: 28707744 [TBL] [Abstract][Full Text] [Related]
13. Differences in subtype distribution between screen-detected and symptomatic invasive breast cancer and their impact on survival. Kobayashi N; Hikichi M; Ushimado K; Sugioka A; Kiriyama Y; Kuroda M; Utsumi T Clin Transl Oncol; 2017 Oct; 19(10):1232-1240. PubMed ID: 28409323 [TBL] [Abstract][Full Text] [Related]
14. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. Carey LA; Perou CM; Livasy CA; Dressler LG; Cowan D; Conway K; Karaca G; Troester MA; Tse CK; Edmiston S; Deming SL; Geradts J; Cheang MC; Nielsen TO; Moorman PG; Earp HS; Millikan RC JAMA; 2006 Jun; 295(21):2492-502. PubMed ID: 16757721 [TBL] [Abstract][Full Text] [Related]
15. Feasibility of risk assessment for breast cancer molecular subtypes. McCarthy AM; Ehsan S; Hughes KS; Lehman CD; Conant EF; Kontos D; Armstrong K; Chen J Breast Cancer Res Treat; 2024 Nov; 208(1):103-110. PubMed ID: 38916820 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry defined subtypes of breast cancer in 678 Sudanese and Eritrean women; hospitals based case series. Sengal AT; Haj-Mukhtar NS; Elhaj AM; Bedri S; Kantelhardt EJ; Mohamedani AA BMC Cancer; 2017 Dec; 17(1):804. PubMed ID: 29191181 [TBL] [Abstract][Full Text] [Related]
17. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status. Ma H; Lu Y; Malone KE; Marchbanks PA; Deapen DM; Spirtas R; Burkman RT; Strom BL; McDonald JA; Folger SG; Simon MS; Sullivan-Halley J; Press MF; Bernstein L BMC Cancer; 2013 May; 13():225. PubMed ID: 23642215 [TBL] [Abstract][Full Text] [Related]
18. Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type. Dilorenzo G; Telegrafo M; La Forgia D; Stabile Ianora AA; Moschetta M Eur J Radiol; 2019 Apr; 113():148-152. PubMed ID: 30927939 [TBL] [Abstract][Full Text] [Related]
19. Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer. Park C; Park K; Kim J; Sin Y; Park I; Cho H; Yang K; Bae BN; Kim KW; Ahn S; Gwak G World J Surg Oncol; 2016 Sep; 14(1):244. PubMed ID: 27619909 [TBL] [Abstract][Full Text] [Related]
20. Breast cancer recurrence according to molecular subtype. Shim HJ; Kim SH; Kang BJ; Choi BG; Kim HS; Cha ES; Song BJ Asian Pac J Cancer Prev; 2014; 15(14):5539-44. PubMed ID: 25081661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]